Pay bone-marrow donors, save lives
from The Wall Street Journal
Doug Grant wants to save lives. Thousands of them. And he wants to do it better, faster and for less money than anyone else. But Mr. Grant and his health-care startup, Hemeos, are suspended in a bureaucratic limbo — their fate in the hands of federal regulators who haven't made a decision after nearly three years of dithering over a proposed rule. Hemeos is aimed at one of the most pressing problems in medicine: the shortage of bone-marrow donors to combat deadly blood diseases. Hemeos plans to revolutionize donor recruitment by taking one simple step: compensating donors with a check for around $2,000. As with every other valuable thing in the world, we will get more marrow cells when we pay for them. It's Econ 101.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063